Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416518 · ClinicalTrials.gov registry record
Genetic Exploration of the Molecular Basis of Malignancy in Adults
A clinical trial of Neoplasms, sponsored by Sanford Health.
- Completed
- Registry status
- 120
- Enrollment target
- 4
- Study locations
NCT02416518: Completed study of Neoplasms, sponsored by Sanford Health.
NCT02416518 is a study of Neoplasms that has completed, run by Sanford Health. The registered enrollment target is 120 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02416518, a study of Neoplasms, has completed, sponsored by Sanford Health.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
Genetic Exploration of the Molecular Basis of Malignancy in Adults.
Primary Outcome
Assess the feasibility of integrating genomic profiling in the adult oncology clinic within a community-based, multi-facility, health system. Feasibility is defined as the proportion of patients with successful molecular profiling compared to the number of patients enrolled.
Conditions Studied
Study Locations (4)
North Dakota
- Sanford Health - Bismarck
- Sanford Health - Fargo
Minnesota
- Sanford Health - Bemidji
South Dakota
- Sanford Health - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-12 |
What the finished NCT02416518 record still lists
NCT02416518 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT02416518 reports a single indexed study location in North Dakota, Minnesota, South Dakota.
Frequently Asked Questions
What is clinical trial NCT02416518 about?
NCT02416518 is a clinical study titled "Genetic Exploration of the Molecular Basis of Malignancy in Adults". Genetic Exploration of the Molecular Basis of Malignancy in Adults.
What is the current status of trial NCT02416518?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-05. Estimated completion is 2018-12.
What conditions does trial NCT02416518 study?
This clinical trial studies the following conditions: Neoplasms.
Who is sponsoring clinical trial NCT02416518?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02416518 being conducted?
This trial has 4 study locations across Minnesota, North Dakota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02416518's enrollment target sits among peer trials
120 65th of 158 higher than 93 of 158 other Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia